TY  - GEN
AU  - Martin,Miguel
AU  - Brase,Jan C
AU  - Ruiz,Amparo
AU  - Prat,Aleix
AU  - Kronenwett,Ralf
AU  - Calvo,Lourdes
AU  - Petry,Christoph
AU  - Bernard,Philip S
AU  - Ruiz-Borrego,Manuel
AU  - Weber,Karsten E
AU  - Rodriguez,César A
AU  - Alvarez,Isabel M
AU  - Segui,Miguel A
AU  - Perou,Charles M
AU  - Casas,Maribel
AU  - Carrasco,Eva
AU  - Caballero,Rosalía
AU  - Rodriguez-Lescure,Alvaro
TI  - Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
SN  - 1573-7217
PY  - 2016///1213
KW  - Antineoplastic Agents, Hormonal
KW  - therapeutic use
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - methods
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Prognosis
KW  - Receptor, ErbB-2
KW  - genetics
KW  - Receptors, Estrogen
KW  - Risk Assessment
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1007/s10549-016-3725-z
ER  -